AXSM: Axsome Corp Forvard P/S multiplikatori
Axsome Therapeutics (AXSM) migren va depressiyaga qarshi kurashish uchun ilg'or kimyoviy usullarni joriy qilmoqda. Forward P/S tendentsiyasi bozor kutganlarini vizuallashtiradi, bunda 8.80 ushbu ko'rsatkichning bazaviy qiymatini aks ettiradi. Qarzni optimallashtirish Altsgeymer terapiyasidagi mustahkam ilmiy salohiyat va sotuvlarning tezkor kengayishiga asoslangan bo'lib, bu operatsion leveraj orqali sof marjani samarali oshiradi.
Axsome Corp (AXSM) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Axsome Therapeutics|AXSM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Axsome Therapeutics|AXSM - Kompaniyaning jamlangan qarzdorligi|Balans kapitallashuviga qarzlar Axsome Corp|AXSM - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Axsome Therapeutics|Tezkor likvidlik ko‘rsatkichi axsome.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
AXSM - Soliqlar to‘langandan keyingi foyda|Prognoz qilingan kelajakdagi foyda Axsome Therapeutics|AXSM - Biznesning o‘zini qoplash muddati|Forvard P/E multiplikatori Axsome Therapeutics Inc|AXSM - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Axsome Corp|AXSM - Amortizatsiya chegirilmasdan oldingi operatsion daromad|Bir aksiya uchun sof foyda (EPS TTM) Axsome Therapeutics|AXSM - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi axsome.com|AXSM - Bu yil bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Axsome Therapeutics
- tushum va sotuvlar tafsilotlari:
Fundamental baholash:Axsome Therapeutics, Inc. AXSM
Axsome Therapeutics (AXSM) dori vositalarining nevrologiya klinikalariga tarqatilishining faol kengayishi kompaniyaning forward P/S grafigi trayektoriyasiga bevosita ta'sir ko'rsatadi. Ushbu ko'rsatkich joriy bozor kapitalizatsiyasini prognoz qilingan yillik daromad bilan solishtiradi, bu esa investorlarga narxga kiritilgan bozor optimizmi darajasini baholash va aktivning kutilayotgan savdo o'sish sur'atlariga nisbatan haddan tashqari sotib olinganlik xavfini aniqlash imkonini beradi.
Raqobatchilar tahlili
Biogen - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati NBIX (Neurocrine)|Regencell - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ACAD (ACADIA Corp)|XENE: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati vikingtherapeutics.com (VKTX)|Narxning prognoz qilingan daromadga nisbati Supernus|CPRX: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori DNLI|Forvard P/S multiplikatori Harmony Corp (HRMY)|Narxning prognoz qilingan daromadga nisbati Biohaven Ltd. BHVN|AMLX (amylyx.com) - Kelajakdagi narxning daromadga nisbati|Trevi Therapeutics, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Praxis Precision Medicines Inc|AVXL (Anavex Corp) - Forvard narx/daromad multiplikatori|CeriBell EEG (CBLL) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori PRTA|ALEC (Alector Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori ANNX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati omeros.com|Forvard P/S multiplikatori NGNE (Neurogene Corp)|ACIU - Forvard narx/daromad multiplikatori|VYGR - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati neumoratx.com NMRA|SCLX: Forvard P/S multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori ACOG|Kapitalizatsiyaning prognoz qilingan daromadga nisbati CGTX (Cognition Therapeutics Inc.)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati cassavasciences.com|Narxning prognoz qilingan daromadga nisbati Assertio ASRT|COYA - Forvard narx/daromad multiplikatori|VTGN - Narxning prognoz qilingan daromadga nisbati|OVID (Ovid Therapeutics Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ABOS: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati cervomed.com (CRVO)|Forvard narx/daromad multiplikatori ATHE|Forvard P/S multiplikatori Clene Nanomedicine|Narxning prognoz qilingan daromadga nisbati PepGen Inc. (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics RLMD|annovisbio.com (ANVS) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF - Forvard P/S multiplikatori|KLTO (anewmeds.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati NRSN|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals|MetaVia, Inc. (MTVA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati NeurAxis (NRXS)|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Passage Bio PASG|NEUP - Forvard narx/daromad multiplikatori|Minerva Neurosciences - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati athira.com|ADXN (Addex Therapeutics Ltd) - Forvard narx/daromad multiplikatori|Alzamend Neuro - Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CYCN|PTIX (Protagenic) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|CRGT (cortigent.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|Brainstorm Cell Therapeutics Inc. (BCLI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|CARA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx CHRO (Chromocell)|ELYM: Forvard P/S multiplikatori|Intra-Cellular Therapies, Inc. (ITCI) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Longboard Pharmaceuticals, Inc.|Marinus Pharmaceuticals Inc - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Sage Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori synaptogen.com SNPX|TRVN: Forvard narx/daromad multiplikatori|Vigil Neuroscience - Narxning kutilayotgan daromadga nisbati|WENA: Forvard P/S multiplikatori|CERE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati
